Skip to main content

What the FDA labels say about taking them together

Metoprolol and tasimelteon

Tasimelteon's FDA label of August 4, 2026 names metoprolol in its drug interactions section; the metoprolol labels PlainMeds reads (4) do not name tasimelteon. The tasimelteon label: “Antagonists Beta-adrenergic receptor antagonists have been shown to reduce the production of melatonin via specific inhibition of beta-1 adrenergic receptors.”

Check it at the source: the metoprolol FDA label on DailyMed (effective March 3, 2026, Melinta Therapeutics, LLC); the tasimelteon FDA label on DailyMed (effective August 4, 2026, Vanda Pharmaceuticals Inc.).

What does the metoprolol label say about tasimelteon?

Metoprolol's label (effective March 3, 2026) and its 3 other brand-application labels do not name tasimelteon in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (TOPROL XL), Melinta Therapeutics, LLC, effective March 3, 2026 (SPL set 496ddfaa-7c9c-4888-b747-a210249b367a), via openFDA; the full label on DailyMed

What does the tasimelteon label say about metoprolol?

Tasimelteon label, drug interactions

Antagonists (e.g., acebutolol, metoprolol) Beta-adrenergic receptor antagonists have been shown to reduce the production of melatonin via specific inhibition of beta-1 adrenergic receptors.

Source: FDA drug label (Hetlioz), Vanda Pharmaceuticals Inc., effective August 4, 2026 (SPL set ca4a9b63-708e-49e9-8f9b-010625443b90), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

74Metoprolol generic labelers
3Tasimelteon generic labelers
MetoprololTasimelteon
Labeled forHigh blood pressure, Angina, Heart failure, Heart attack and coronary artery diseasen/a
Boxed warningNoNo
Pharmacy cost (NADAC)$0.085 per tablet 100 mg tablet$228.25 per capsule 20 mg capsule
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?